Journal: Annals of Translational Medicine

Article Title: DAB2IP decreases cell growth and migration and increases sensitivity to chemotherapeutic drugs in colorectal cancer

doi: 10.21037/atm-21-3474

Figure Lengend Snippet: Summarize of antibodies information used in this study

Article Snippet: The bands were generated using ImageLab (Bio-Rad Laboratories Inc., CA, USA) and then quantified using ImageJ (NIH, USA). table ft1 table-wrap mode="anchored" t5 caption a7 Name Company Catalog number Antibody concentration DAB2IP Abcam ab87811 1:1,000 or 1:500 Flag Medical & Biological Laboratories M185-3L 1:2,000 P53 Cell Signaling Technology 2527 1:1,000 P21 Cell Signaling Technology 2947 1:1,000 Cyclin D1 Cell Signaling Technology 55506 1:1,000 CDK4 Cell Signaling Technology 12790 1:1,000 ZO-1 Cell Signaling Technology 8193 1:1,000 Claudin-1 Cell Signaling Technology 13255 1:1,000 β-Catenin Cell Signaling Technology 8480 1:1,000 Snail Cell Signaling Technology 3879 1:1,000 E-Cadherin Cell Signaling Technology 3195 1:1,000 PARP Cell Signaling Technology 9532 1:1000 P-AKT Cell Signaling Technology 4060 1:1,000 AKT Cell Signaling Technology 4691 1:1,000 P-ERK Cell Signaling Technology 4370 1:1,000 ERK Cell Signaling Technology 4695 1:1,000 Bcl-xL Bimake A5091 1:1,000 Bcl-2 Bimake A5010 1:1,000 GAPDH Abgent AM1020b 1:2,000 Open in a separate window caption a8 Summarize of antibodies information used in this study

Techniques: Concentration Assay